Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Metastasis × sarilumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Ovarian Neoplasms 2 Neoplasms 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Pathologic Complete Response 1 Neoplasm Metastasis 1 Metastatic Castration-resistant Prostate Cancer 1 Melanoma 1 Hemangiosarcoma 1 Breast Neoplasms 1

Interventions

pembrolizumab 43 Specimen Handling 28 Magnetic Resonance Spectroscopy 24 Biopsy 24 Radiosurgery 17 Gemcitabine 14 Nivolumab 12 Cisplatin 11 Paclitaxel 10 Cyclophosphamide 10 Carboplatin 10 Capecitabine 9 Taxes 8 Pemetrexed 8 Leucovorin 8 Irinotecan 8 Fluorouracil 8 Cetuximab 8 Bevacizumab 8 trastuzumab deruxtecan 7 Oxaliplatin 7 Drug Therapy 7 Doxorubicin 7 olaparib 6 cemiplimab 6 abemaciclib 6 Radiotherapy 6 Folfox protocol 6 Docetaxel 6 ribociclib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04333706 2026-03-10

EMPOWER

University of Southern California

Phase 1/2 Recruiting

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡